GE Healthcare Technologies (GEHC) said Monday its imaging platform Allia Moveo has received US Food and Drug Administration 510(k) clearance and CE Marking.
The platform, which aims to assist in a wide range of medical procedures, was first installed at the French medical center Hopital Marie-Lannelongue, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments